PubRank

Douglas E Gladstone

Author PubWeight™ 16.46‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Brief intensive therapy for older adults with newly diagnosed Burkitt or atypical Burkitt lymphoma/leukemia. Leuk Lymphoma 2012 1.57
2 Phase 2 study of rituximab-ABVD in classical Hodgkin lymphoma. Blood 2012 1.23
3 Phase I and pharmacologic trial of cytosine arabinoside with the selective checkpoint 1 inhibitor Sch 900776 in refractory acute leukemias. Clin Cancer Res 2012 1.20
4 Outcomes of related donor HLA-identical or HLA-haploidentical allogeneic blood or marrow transplantation for peripheral T cell lymphoma. Biol Blood Marrow Transplant 2013 1.13
5 Renal cell carcinoma induced Coombs negative autoimmune hemolytic anemia and severe thrombocytopenia responsive to nephrectomy. J Urol 2002 0.97
6 Randomized phase II study of two schedules of flavopiridol given as timed sequential therapy with cytosine arabinoside and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia. Haematologica 2012 0.90
7 Absence of post-transplantation lymphoproliferative disorder after allogeneic blood or marrow transplantation using post-transplantation cyclophosphamide as graft-versus-host disease prophylaxis. Biol Blood Marrow Transplant 2013 0.87
8 The role of growth factors in the activity of pharmacological differentiation agents. Cell Growth Differ 2002 0.87
9 Occurrence of multiple myeloma in both donor and recipient after bone marrow transplantation. Am J Hematol 2002 0.86
10 Cryptococcus albidus infection in a patient undergoing autologous progenitor cell transplant. Transplantation 2004 0.82
11 Maintaining hemostasis in acquired von Willebrand syndrome: a review of intravenous immunoglobulin and the importance of rituximab dose scheduling. Transfusion 2012 0.81
12 High-dose cyclophosphamide without stem cell rescue for refractory multifocal motor neuropathy. Muscle Nerve 2006 0.80
13 Treatment of relapsing-remitting multiple sclerosis with high-dose cyclophosphamide induction followed by glatiramer acetate maintenance. Mult Scler 2011 0.78
14 Bortezomib salvage therapy in refractory acute adult T-cell leukemia/lymphoma. Leuk Lymphoma 2013 0.77
15 High-dose chemotherapy and multiple sclerosis. Curr Opin Oncol 2011 0.75
16 Phase 1 dose-escalation trial of clofarabine followed by escalating dose of fractionated cyclophosphamide in adults with relapsed or refractory acute leukaemias. Br J Haematol 2012 0.75
17 High-dose cyclophosphamide therapy without stem cell rescue for severe refractory autoimmune illnesses: comment on the article by Moore et al. Arthritis Rheum 2003 0.75
18 Sustained remission and reversal of end-organ dysfunction in a patient with anaplastic myeloma. Ann Hematol 2014 0.75
19 Malignant pericardial effusion--an uncommon complication of multiple myeloma: case report. Heart Surg Forum 2005 0.75
20 Quality of life after high-dose cyclophosphamide in patients with severe autoimmune diseases. J Eval Clin Pract 2005 0.75
21 Granulocytic sarcoma presenting as bilateral adrenal masses. Am J Hematol 2005 0.75